Fact-checked by Grok 2 weeks ago

Cold abscess

A cold abscess is a chronic collection of pus that develops gradually without the classic signs of acute inflammation, including redness (erythema), warmth, pain, or tenderness, distinguishing it from typical pyogenic abscesses. These abscesses are most commonly associated with extrapulmonary tuberculosis caused by Mycobacterium tuberculosis, where the infection spreads hematogenously or via lymphatics to form caseous necrotic material enclosed in a fibrous capsule, often in the musculoskeletal system or soft tissues. Less frequently, they arise from other indolent infections, such as deep fungal mycoses (e.g., coccidioidomycosis) or atypical bacterial pathogens like Staphylococcus aureus in immunocompromised hosts, particularly in cases of humoral or cell-mediated immunodeficiency. Clinically, cold abscesses typically manifest as painless, fluctuant subcutaneous or deeper masses that may grow insidiously over weeks to months, sometimes leading to complications like sinus tract formation or adjacent tissue destruction if untreated. Common sites include the chest wall, spine (as in ), neck, and psoas muscle, with chest wall involvement representing a rare but notable extrapulmonary form of affecting approximately 1-5% of skeletal TB cases. Diagnosis relies on imaging (e.g., , , or MRI to assess extent and involvement of bone or muscle), fine-needle aspiration for acid-fast bacilli staining, culture, or confirming granulomatous inflammation, and exclusion of acute bacterial causes via and aerobic/anaerobic cultures. Treatment emphasizes addressing the underlying , with antitubercular (e.g., a regimen of isoniazid, rifampin, pyrazinamide, and ethambutol for at least 6-12 months) as the cornerstone for TB-related cases, often combined with surgical intervention such as or to prevent recurrence and manage complications like rib destruction or formation. For non-tuberculous causes, management may involve agents, antibiotics tailored to results, or supportive care in immunocompromised patients. Despite effective , cold abscesses can mimic neoplasms or other chronic conditions, underscoring the importance of early recognition in high-prevalence regions or at-risk populations to avoid diagnostic delays.

Definition and Characteristics

Definition

A cold abscess is defined as a abscess that forms slowly with little to no evidence of acute . It represents a localized collection of surrounded by a wall of , developing gradually without the typical cardinal signs of , including heat (calor), redness (rubor), pain (dolor), and acute swelling (tumor). The term "cold" specifically denotes the absence of warmth and the subdued inflammatory response, distinguishing it from more overt infectious processes. This nomenclature refers to descriptions of , such as those involving , where such abscesses were noted as indolent complications lacking overt signs of active suppuration. In contrast to acute abscesses, which arise rapidly from high-virulence bacterial infections and exhibit pronounced local and systemic inflammatory features, cold abscesses follow a , insidious progression often linked to low-virulence pathogens that provoke a muted .

Distinctive Features

Cold abscesses present clinically as painless or minimally tender fluctuant masses, lacking the acute inflammatory signs typical of "hot" abscesses, such as redness, warmth, and severe pain. In early stages, affected individuals generally show no systemic fever or , with possible subtle overlying skin discoloration but without . This indolent nature reflects the underlying infectious process, often linked to . Histologically, cold abscesses consist of encapsulated with , especially in tuberculosis-associated cases, surrounded by granulomatous featuring epithelioid histiocytes, multinucleated giant cells, lymphocytes, and cells. Unlike hot abscesses, which exhibit dense polymorphonuclear infiltration, cold abscesses display minimal neutrophilic response, emphasizing a lymphocytic and histiocytic predominance. These lesions progress slowly over weeks to months, allowing for gradual expansion without rapid escalation. Over time, they may develop tracts, though without the acute, copious discharge seen in pyogenic infections.

and

Primary Causes

Cold abscesses are primarily caused by infectious agents, with being the most common etiological factor, accounting for the majority of cases as a form of extrapulmonary . Atypical mycobacteria, such as *, can also lead to cold abscess formation, particularly in immunocompromised individuals. Fungal pathogens like (especially var. duboisii in African histoplasmosis) are implicated in endemic regions among those with . Chronic bacterial infections, including methicillin-resistant Staphylococcus aureus (MRSA), may cause cold abscesses in specific sites such as the psoas muscle, particularly in immunocompromised hosts. Other bacterial causes include enteric pathogens like and in rare cases. Predisposing factors significantly contribute to the development of cold abscesses, primarily through impairment of immune responses. , notably from infection, increases the risk of by 16-27 times compared to the general population, with extrapulmonary forms such as cold abscesses being more prevalent among HIV-infected individuals (up to 50% of TB cases in HIV vs. 15-20% in non-HIV). Post-COVID-19 immune dysregulation has been associated with heightened susceptibility to tuberculosis reactivation, including extrapulmonary manifestations. , including deficiencies in vitamins A and D as well as , weakens cellular immunity and elevates risk, with undernutrition roughly doubling the short-term incidence (RR 1.95, 95% CI 1.72-2.20). Socioeconomic conditions such as and overcrowding facilitate transmission, while alcohol use disorder and reactivation further predispose individuals. Although predominantly infectious, rare non-infectious causes include atypical presentations in autoimmune conditions, such as aseptic abscess syndrome in , where sterile neutrophilic collections mimic cold abscesses without microbial involvement. Rarely, other pathogens like () or macrolide-resistant in primary immunodeficiencies have been reported to cause cold abscesses as of 2025.

Pathophysiological Mechanisms

Cold abscesses primarily arise in the context of tuberculosis infection by Mycobacterium tuberculosis, through specific routes of bacterial dissemination that facilitate localized collection of necrotic material. Hematogenous spread from primary pulmonary foci enables mycobacteria to reach distant extrapulmonary sites, where they establish foci that evolve into abscesses. Contiguous extension from adjacent infected tissues, such as vertebral bodies in spinal tuberculosis (), allows direct propagation of infection leading to abscess formation. Lymphatic involvement, particularly in regional nodes like the cervical chain, further contributes to abscess development by channeling bacteria to nearby soft tissues. The host immune response to M. tuberculosis is characterized by cell-mediated delayed-type , primarily driven by CD4+ T cells producing interferon-gamma (IFN-γ) to activate macrophages. This response orchestrates formation, comprising central epithelioid macrophages, Langhans giant cells, and surrounding lymphocytes, which aims to contain . Within the , central occurs due to the death of lipid-laden macrophages, providing a nutrient-rich environment that sustains mycobacterial persistence; the resulting avascular, fibrotic structure limits neutrophil infiltration and acute inflammatory signs. Liquefaction of this caseous material over time forms an encapsulated collection of , devoid of the typical warmth and of pyogenic abscesses. Chronicity of cold abscesses stems from M. tuberculosis's adapted strategies, including slow intracellular and immune evasion mechanisms that inhibit phagolysosomal and in host cells, thereby delaying clearance. These factors permit gradual tissue and liquefaction without eliciting a vigorous pyogenic response, fostering indolent progression.

Clinical Manifestations

Symptoms

Cold abscesses typically present with subtle local symptoms that lack the acute inflammatory signs seen in pyogenic abscesses, such as redness, warmth, or significant pain. The hallmark is an indolent, painless swelling that feels fluctuant on palpation due to the accumulation of caseous necrotic material. Tenderness is minimal or absent unless secondary bacterial occurs, contributing to the "cold" designation of these lesions. In cases associated with , additional local features may include gradual firmness from underlying granulomatous . Systemic symptoms are often absent in the early stages, with rare occurrences of low-grade fever or mild reflecting the chronic, low-virulence nature of the underlying . As the condition progresses without treatment, particularly in disseminated , patients may develop fatigue, anorexia, weight loss, or due to the systemic effects of mycobacterial dissemination. The abscess enlarges slowly over weeks to months, often remaining until it reaches a significant size or involves adjacent structures. Untreated, it carries a risk of spontaneous rupture, resulting in a thin serous or caseous discharge rather than thick , potentially forming a tract.

Anatomical Sites

Cold abscesses, primarily associated with , most commonly develop in the and , presenting as painless swellings typically measuring 3-5 cm in diameter. These involvements account for a significant portion of extrapulmonary cases, with sites being the most frequent manifestation due to hematogenous or lymphatic spread. Chest wall cold abscesses arise from extension of pleural or pulmonary and represent 1-5% of all musculoskeletal tuberculosis cases. In endemic regions such as , these abscesses show a higher incidence, with an average patient age of 39.1 years and a male predominance (75%). Non-tuberculous cold abscesses, such as those from deep fungal infections, may involve similar sites but often occur in immunocompromised hosts with more prominent systemic symptoms. Spinal involvement leads to Pott's abscess, often in the vertebral bodies, where the abscess forms paravertebrally and may cause neurological deficits such as due to cord . Psoas muscle abscesses, resulting from spinal or gastrointestinal spread, commonly present with a characteristic hip flexion posture and limited extension. Rare sites include the , where tuberculous abscesses manifest as tuberculomas potentially causing headaches or seizures; the liver, often in disseminated disease; and the kidneys, as a complication of renal tuberculosis involving calyceal destruction.

Diagnostic Approaches

Clinical Evaluation

Clinical evaluation of a suspected cold abscess begins with a detailed history to identify risk factors and contextualize the presentation. Patients should be queried regarding prior exposure to , such as contact with infected individuals or a personal history of pulmonary , which is reported in up to 30% of cases in some series. Inquiry into , including status, is essential, as it increases susceptibility to extrapulmonary manifestations like cold abscesses. or immigration from tuberculosis-endemic regions should also be assessed, given the higher prevalence in such populations. The history typically reveals a gradual onset of symptoms over weeks to months, often without preceding trauma, distinguishing it from acute pyogenic processes. Physical examination focuses on identifying characteristic local findings while ruling out signs of acute . often reveals a non-tender, fluctuant mass that is soft and well-defined, lacking overlying , warmth, or significant induration—hallmarks of the "cold" nature of these abscesses. Assessment for associated is crucial, particularly in or supraclavicular regions, where painless nodal enlargement may accompany the . In cases involving the spine, such as , examination should include evaluation for spinal deformity like gibbus or due to vertebral destruction, along with checks for muscle or . Systemic examination may uncover subtle constitutional signs, though these are often absent in localized disease. Red flags warranting urgent evaluation include neurological symptoms in spinal involvement, such as , , or sensory deficits from cord , which occur in 10-76% of advanced cases. Evidence of systemic illness, including persistent fever, significant , or , should prompt heightened suspicion for disseminated . If clinical findings suggest a cold abscess, techniques can provide confirmatory detail.

Imaging Techniques

Ultrasound serves as an initial non-invasive imaging modality for evaluating superficial , particularly in sites such as the or chest wall. It typically reveals hypoechoic cystic with internal , heterogeneous , and possible posterior acoustic enhancement, aiding in the assessment of extent and guiding . Computed tomography (CT) is the preferred imaging technique for deep-seated or chest wall cold abscesses, providing characteristic features suggestive of tuberculous etiology, such as rim-enhancing fluid collections and associated complications like pleural involvement or bone erosion; one reported a 91% rate for TB using CT-guided . Contrast-enhanced CT scans demonstrate low-attenuation abscesses with peripheral enhancement, facilitating evaluation of anatomical relationships and extension. Magnetic resonance imaging (MRI) provides superior soft tissue contrast and is optimal for spinal or psoas cold abscesses, clearly delineating paravertebral extension, muscle involvement, and bone destruction such as vertebral body collapse in . T2-weighted sequences show hyperintense abscesses with thin rim enhancement on post-contrast images, while T1-weighted images highlight marrow edema and . Despite their utility, imaging techniques like and MRI do not identify the causative , necessitating microbiological correlation for definitive . Additionally, involves , raising concerns for repeated use in pediatric patients.

Laboratory and Microbiological Tests

Laboratory investigations for cold abscesses typically begin with blood tests to assess and screen for underlying predispositions. (ESR) is often mildly elevated, typically above 20 mm/h but lower than in acute bacterial abscesses due to the indolent nature of the infection, while (CRP) levels are similarly raised, providing a more specific indicator of ongoing . The Mantoux tuberculin skin test, involving of purified protein derivative, shows an induration greater than 15 mm as suggestive of (TB) exposure, though its sensitivity for extrapulmonary TB sites like cold abscesses is reduced at 40-55%. serology is routinely performed, as co-infection significantly increases the risk of extrapulmonary TB manifestations. Fine-needle aspiration cytology () or aspiration of the abscess fluid is a key procedure for direct sampling, often revealing , epithelioid granulomas, and Langhans giant cells on cytological examination. for acid-fast (AFB) on aspirated material detects in 25-75% of cases, with higher yields in samples compared to other extrapulmonary sites. The assay, a nucleic acid amplification test (NAAT), provides rapid detection of M. tuberculosis DNA and rifampicin resistance, achieving sensitivities of 80-90% in extrapulmonary specimens such as abscess fluid. Mycobacterial culture remains the gold standard for definitive identification, using Lowenstein-Jensen (LJ) solid media which requires 4-6 weeks for growth, with a of approximately 47% in extrapulmonary TB. Biopsy specimens from the abscess wall, when obtained, undergo to confirm granulomatous with , supporting a TB in 72-97% of cases. In non-TB cold abscesses, such as those caused by (NTM) or fungi, routine bacterial and fungal cultures of aspirated fluid are essential, yielding positive results in about 65% of NTM cases; fungal serology may be indicated in endemic areas for pathogens like .

Treatment Strategies

Pharmacological Management

The pharmacological management of cold abscesses primarily targets the underlying infectious etiology, with antituberculous therapy forming the cornerstone for Mycobacterium tuberculosis-associated cases, which constitute the majority. The standard regimen for drug-susceptible extrapulmonary tuberculosis, including cold abscesses, follows the (DOTS) strategy recommended by the . This involves an intensive phase of 2 months with daily administration of isoniazid (5 mg/kg), rifampicin (10 mg/kg), pyrazinamide (25 mg/kg), and ethambutol (15 mg/kg), followed by a continuation phase of 4 months with isoniazid and rifampicin alone, for a total duration of 6 months in most cases. For spinal or more extensive extrapulmonary involvement, such as with cold abscess, the total duration is extended to 9-12 months to ensure complete resolution and prevent relapse. Adherence is monitored through directly observed therapy to minimize resistance development and treatment failure. For non-tuberculous causes, treatment is etiology-specific and guided by and sensitivity results. Bacterial cold abscesses, such as those due to (MRSA), are managed with intravenous (15-20 mg/kg every 8-12 hours, adjusted for renal function) for 4-6 weeks, often transitioning to oral or clindamycin if susceptible. Nontuberculous mycobacterial (NTM) infections require prolonged multidrug regimens, typically including a (e.g., 500 mg twice daily), ethambutol (15 mg/kg daily), and rifampin (10 mg/kg daily) for a minimum of 6 months beyond clinical and culture-negative resolution. Fungal etiologies, like , necessitate induction with liposomal (3-5 mg/kg daily for 1-2 weeks), followed by oral (200 mg three times daily) for 6-12 months total, particularly in disseminated or immunocompromised cases. Supportive pharmacological measures address nutritional deficiencies and symptoms to enhance recovery, especially in immunocompromised patients. Supplementation with (10,000 IU daily), (2,000-4,000 IU daily), and (15-30 mg daily) is recommended during antituberculous therapy to support immune function and accelerate sputum conversion, though it does not universally improve all treatment outcomes. Analgesics such as acetaminophen (up to 4 g daily) may be used sparingly if localized develops, despite the typically indolent nature of cold abscesses. Therapeutic monitoring is essential to assess response and manage adverse effects. Monthly clinical evaluations, including repeat cultures or sputum analysis where applicable, guide regimen adjustments and confirm microbiological clearance. Liver function tests should be performed monthly due to the risk of hepatotoxicity from antituberculous drugs, which occurs in 3-25% of patients, manifesting as elevated transaminases or jaundice; prompt discontinuation and rechallenge with modified regimens are required if severe.

Surgical Interventions

Surgical interventions for cold abscesses, typically associated with tuberculous infections, are indicated in cases of large abscesses that fail to respond to , neurological compression due to spinal involvement, or progression despite medical . For instance, is recommended when there is neurological deficit, spinal instability, or advanced disease where impedes antibiotic penetration. In spinal with paravertebral or psoas cold abscesses, indications include failure of nonoperative treatment after 3-6 months or severe . Common techniques vary by location and abscess characteristics. For small, superficial abscesses, needle under or guidance suffices to evacuate pus and confirm diagnosis. (I&D) combined with is standard for chest wall or spinal abscesses, involving complete excision of the abscess wall, , and obliteration of to prevent recurrence; resection may be added if bony involvement is present. For deep-seated psoas or paravertebral abscesses, -guided (PCD) with continuous lavage using anti-tubercular agents like isoniazid is a minimally invasive approach, often performed under and continued for 3-6 weeks. In complex spinal cases, anterior or corpectomy may accompany to relieve cord compression, followed by grafting for stability. Postoperative care emphasizes wound management and continuation of anti-tubercular to eradicate the underlying . Wounds from I&D are typically packed to promote healing by secondary intention, with regular dressing changes to monitor for . Patients receive 6-9 months or longer of multidrug anti-tubercular regimens post-surgery, alongside pain control and as tolerated; hospital stays average 6-7 days for uncomplicated chest wall cases. In tuberculous cold abscesses, combining with anti-tubercular achieves cure rates of 96-100%, with solid bony union and symptom resolution in most patients followed long-term. Potential risks include bleeding, secondary bacterial infection, , and recurrence, particularly if is not adequately addressed. Recurrence rates in musculoskeletal tuberculous cold abscesses range from 3-15%, lower (around 4%) with comprehensive and rib resection compared to simple drainage alone; preoperative anti-tubercular therapy can further mitigate postoperative complications like or formation.

Prognosis and Complications

Prognostic Factors

The prognosis of cold abscess, a manifestation of extrapulmonary (TB), is generally favorable with appropriate management, particularly in isolated cases where resolution rates reach 80-90% following combined medical and surgical interventions. Early significantly improves outcomes by preventing progression to more severe involvement and ensuring uncomplicated resolution. Adherence to a standard 6-9 month regimen of anti-tuberculosis therapy (ATT) further enhances success, with high cure rates (up to 100% in reported series) in uncomplicated drug-susceptible cases. Absence of is associated with better recovery. Conversely, several negative factors adversely affect long-term outcomes. Delayed , particularly beyond six months, often leads to irreversible destruction and poorer functional , with durations exceeding six months associated with increased of neurological deficits or in spinal or osteoarticular cases. co-infection substantially worsens prognosis, elevating mortality by 20-30% compared to non-co-infected TB patients due to accelerated disease progression and challenges. Similarly, multidrug-resistant TB (MDR-TB) reduces success to less than 70%, as evidenced by global rates of 68% (as of 2021) for rifampicin-resistant cases, necessitating prolonged and more complex regimens. Overall, isolated cold abscesses carry an excellent with 80-90% resolution under standard care, whereas disseminated disease yields poorer results due to systemic involvement and higher complication risks. Routine follow-up with clinical and for at least two years is recommended to monitor response and detect residual lesions early. For non-tuberculous cold abscesses, depends on the underlying ; fungal or atypical bacterial causes often respond well to targeted or , though immunocompromised patients may experience higher rates of or complications.

Associated Complications

Cold abscesses, often arising from tuberculous infections, can lead to several local complications if left untreated or inadequately managed. One common issue is the formation of tracts, which allow for chronic drainage of caseous material and perpetuate through persistent communication between the abscess and the skin surface. These tracts may result in recurrent abscesses and scarring, particularly in spinal or paraspinal locations. Additionally, secondary bacterial can occur, transforming the indolent cold abscess into an acute hot abscess with increased , , and pain due to polymicrobial involvement. Tissue , characterized by caseous degeneration, is frequently observed within the abscess walls, contributing to structural damage in surrounding soft or . Systemic complications arise from the hematogenous spread of infection or prolonged inflammatory response. Untreated cold abscesses, especially in spinal (), carry a 10-20% risk of neurological involvement, including due to cord compression from abscess extension or vertebral instability. Dissemination may lead to affecting the lungs or brain, representing a severe form of widespread disease originating from extrapulmonary foci. Chronic inflammation from persistent abscesses can also induce secondary (AA type), with identified as a leading predisposing factor in up to 20% of renal amyloidosis cases in endemic regions. Rare but serious events include formation to adjacent structures, such as pleural fistulas resulting in , particularly in chest wall es. Rupture of an can precipitate , though this is uncommon. Overall, epidemiological data indicate low complication rates (1-5%) when prompt antitubercular therapy (ATT) and surgical intervention are employed, underscoring the role of early treatment in prevention.

References

  1. [1]
    Cold subcutaneous abscesses - PubMed
    ... cold abscess pathogenesis. In addition, therapeutic guidelines for abscesses are reviewed. Publication types. Case Reports. MeSH terms. Abscess / microbiology ...
  2. [2]
    Tuberculous cold abscess of the chest wall: A clinical and surgical ...
    Feb 13, 2020 · Tuberculosis of the chest wall is rare and often presents as cold abscess (to differentiate from pyogenic abscess) or pseudotumoral mass whose diagnosis is ...Missing: definition | Show results with:definition
  3. [3]
    Multiple Cold Abscesses of a Chest Wall with Ribs Destruction in a ...
    Feb 1, 2024 · Cold abscess of the chest wall is an uncommon disease that is mainly caused by tuberculous infection. Staphylococcal cold abscesses of the ...Missing: definition | Show results with:definition
  4. [4]
    Cold subcutaneous abscesses - PMC - NIH
    ... cold abscess pathogenesis. In addition, therapeutic guidelines for abscesses ... Articles from Journal of the National Medical Association are provided here ...
  5. [5]
    [PDF] Surgical Treatment of Tuberculous Cold Abscess of the Chest Wall
    The incidence of tuberculosis (Tbc) infection is high in some parts of the world and tuberculous cold abscess of the chest wall (CACW) often fails to respond to ...
  6. [6]
    Pott Disease - StatPearls - NCBI Bookshelf - NIH
    Tuberculosis (TB), as a disease has been known since ancient times. It was described as early as 1000 to 600 BCE as "Yakshama" in ancient Indian medical ...
  7. [7]
    Musculoskeletal Tuberculosis - PMC - PubMed Central - NIH
    This photograph demonstrates a cold abscess of the chest wall in a patient with TB. ... CLINICAL FEATURES. The onset of musculoskeletal TB is usually an ...<|control11|><|separator|>
  8. [8]
    Tuberculous cold abscess of breast: an unusual presentation in a ...
    Keywords: Mammary tuberculosis (mammary TB), cold abscess, breast abscess, tuberculosis (TB) ... Breast tuberculosis: diagnosis, clinical features & management.
  9. [9]
    Primary Orbital Tuberculosis with Cold Abscess: A Case Report - NIH
    Feb 29, 2024 · Primary Orbital Tuberculosis with Cold Abscess ... Diagnosis of orbital tuberculosis is based on clinical, radiological and histological features ...
  10. [10]
    Non-tuberculous cutaneous mycobacterioses
    Non-tuberculous mycobacteriosis, previously known as atypical, anonymous, opportunistic, or unclassified mycobacteriosis, refers to pathogenic ...
  11. [11]
    Non-tuberculosis cold abscess - PubMed
    The results of abscess culture later revealed Proteus mirabilis, Escherichia coli, and Prevotella melaninogenica. This is the first report of a cold abscess ...
  12. [12]
    TB-HIV, TB-Diabetes, Undernutrition and other co-morbidities
    Aug 12, 2020 · People living with HIV are 16-27 times more likely to develop TB, and TB accounts for 32 percent of deaths among people with HIV. More TB cases ...
  13. [13]
    Tuberculosis in individuals who recovered from COVID-19
    Nov 28, 2022 · COVID-19 and TB share dysregulation of immune responses that could worsen COVID-19 severity and may favor TB disease progression and ...<|control11|><|separator|>
  14. [14]
    Micronutrient supplementation in individuals with active tuberculosis
    Aug 9, 2023 · Undernutrition increases the risk of tuberculosis and vice-versa and ... Low circulating concentrations of micronutrients, such as vitamins A, E ...
  15. [15]
    Spinal Tuberculosis and Cold Abscess without Known Primary ...
    Regarding cold abscesses, conservative therapy is not enough to prevent vertebral destruction; immediate drainage combined with medical therapy is needed.
  16. [16]
    Aseptic Abscess Syndrome in Rheumatoid Arthritis Patient - MDPI
    Aseptic abscess syndrome (AAS) is a rare, potentially life-threatening disorder, with numerous features of neutrophilic dermatoses.
  17. [17]
    Tuberculous cold abscess of the chest wall masquerading as ...
    Apr 30, 2021 · Chest wall TB may occur by means of three mechanisms: (a) hematogenous dissemination (b) direct extension from lymphadenitis of chest wall,[4] ...
  18. [18]
    Pathogenesis, Diagnostic Challenges, and Risk Factors of Pott's ...
    Jan 25, 2023 · Cold abscesses are also commonly associated with spinal TB and are typically located near the initial lesion [4]. A cold abscess denotes an ...<|control11|><|separator|>
  19. [19]
    Immunity and Immunopathology in the Tuberculous Granuloma - PMC
    On the one hand, pathogenic mycobacteria accelerate and exploit granuloma formation for their expansion and dissemination by manipulating host immune responses ...
  20. [20]
    Tuberculosis (TB): Background, Pathophysiology, Etiology
    Oct 31, 2024 · Long term efficacy of DOTS regimens for tuberculosis: systematic review. BMJ. 2008 Mar 1. 336(7642):484-7. [QxMD MEDLINE Link].[Full Text] ...
  21. [21]
    Immune evasion and provocation by Mycobacterium tuberculosis
    Jul 25, 2022 · In this Review, Chandra, Grigsby and Philips discuss how Mycobacterium tuberculosis evades immune-mediated clearance while capitalizing on the host ...
  22. [22]
    Isolated primary cold abscess of the sternum: a case report
    Aug 25, 2019 · Primary tuberculous sternal osteomyelitis accounts for approximately 0.3% of all types of tubercular osteomyelitis and the probable source ...
  23. [23]
    Sonographic Features of a Tuberculous Cold Abscess:A Case ...
    Apr 1, 2023 · Bacterial abscesses are typically warm, red, and tender to touch (characteristic signs of inflammation). However, a cold abscess lacks such ...
  24. [24]
    Practice Essentials, Pathophysiology of Scrofula, Epidemiology of ...
    Aug 17, 2023 · More than 50 species have now been identified, of which one half are recognized as pathogenic. Statistics indicate an increase in the prevalence ...
  25. [25]
    A Case of Traumatic Drainage of Cold Abscess - ScienceDirect.com
    TB is characterized by cold abscess, which classically lacks the usual signs and symptoms of inflammation. Typical history of low-grade evening rise of fever, ...
  26. [26]
    Treatment for 15 Cases of Cervical Tuberculosis - PMC
    Sometimes, a progressive abscess was subsequently treated with open drainage, or spontaneous rupture of an abscess led to inevitable fistula formation, so ...
  27. [27]
    Clinical Manifestations - Tuberculosis in Adults and Children - NCBI
    Other complications are overlying violaceous skin inflammation and cold abscess formation. Tenderness or pain is not typically described, unless there is ...Tuberculosis In Adults And... · Chapter 3clinical... · 3.3. 1. Pleural Tuberculosis<|separator|>
  28. [28]
    TB or not TB? The axillary lump question - Annals Singapore
    Sep 26, 2022 · TB scrofuloderma should be considered in a painless, indurated axillary skin nodule with the sonographic finding of an underlying abscess ...
  29. [29]
    Cervical tuberculous lymphadenitis - PMC - PubMed Central - NIH
    May 6, 2021 · Neck examination revealed right supraclavicular swelling measuring 5×6 cm, fluctuant with no visible punctum, tender and erythematous looking ( ...
  30. [30]
    Tuberculous cervical lymphadenitis | Radiology Reference Article
    Jan 21, 2025 · Tuberculous cervical lymphadenitis is the most common manifestation of extrapulmonary tuberculosis and is a very frequent cause of a peripheral lymphadenitis ...
  31. [31]
    Chest wall soft-tissue tuberculosis: A case report - SciELO México
    Sep 6, 2021 · Chest wall tuberculosis (TB) is a rare condition, making up 1-5% of all musculoskeletal TB cases. We report a case of a 39-year-old woman with a palpable mass ...
  32. [32]
    Pott Disease (Tuberculous [TB] Spondylitis) - Medscape Reference
    Oct 21, 2024 · A cold abscess can occur if the infection extends to adjacent ligaments and soft tissues. Abscesses in the lumbar region may descend down ...Missing: 19th | Show results with:19th
  33. [33]
    Iliopsoas Abscess Infection - Dr. Nabil Ebraheim's Blog
    Mar 13, 2018 · With psoas involvement, the hip appears to be flexed, with limited and painful range of motion. This diverts attention away from the abdomen or ...<|separator|>
  34. [34]
    Isolated psoas abscess caused by Mycobacterium tuberculosis - NIH
    Psoas tuberculosis abscess is very rarely detected primarily without an adjacent vertebral cold abscess. Early diagnosis prevents unnecessary operations.
  35. [35]
    Tuberculous abscess: Symptoms, treatment, and outlook
    Dec 20, 2023 · Tuberculosis (TB) primarily affects the lungs. However, TB-causing bacteria can lead to pus collecting in the tissues. This is known as an abscess.
  36. [36]
    Tuberculosis | SpringerLink
    The abscesses may develop in the liver, lungs, or kidneys. Patients often present with fever, sepsis syndrome, and splenomegaly. This form of TB has been ...
  37. [37]
    Kidney Tuberculosis - an overview | ScienceDirect Topics
    Kidney tuberculosis is defined as a late and uncommon complication of pulmonary tuberculosis, characterized by the presence of tubercle bacilli in the urine ...Renal Infectious Diseases · Respiratory System · Tuberculosis In Travelers...<|separator|>
  38. [38]
    Tuberculosis (TB) Clinical Presentation: History, Physical Examination
    Oct 31, 2024 · Physical examination findings associated with TB depend on the organs involved. Patients with pulmonary TB have abnormal breath sounds, ...History · Pulmonary Tb · Tuberculous Meningitis
  39. [39]
    Unusual cervicofacial localization of two subcutaneous tuberculous ...
    Jul 9, 2021 · The diagnosis of subcutaneous tuberculous cold abscesses is based on a combination of anamnestic, clinical and paraclinical findings. Cold ...
  40. [40]
    Sonographic Features of a Tuberculous Cold Abscess - NIH
    Apr 26, 2023 · Anatomical sites for EPTB include pleura, joints, bones, lymph nodes, urogenital tract and meninges. Constitutional symptoms such as fever, ...
  41. [41]
    Cervicothoracic cold abscess - tuberculosis | Radiology Case
    Jan 9, 2020 · Ultrasound scan showed ill-defined thick irregular walled collection on right side of neck with caudal retrosternal extension.
  42. [42]
    Contribution of computed tomography guided percutaneous ...
    Our purpose is to determine the accuracy of imaging tuberculous cold abscesses with CT scan. Most of these cold abscesses are pharmaceutically and surgically ...
  43. [43]
    Radiological Evaluation of a Rare Case of Rib Caries and Cold ...
    Feb 16, 2023 · Rib caries with a cold abscess is a rare presentation of tuberculosis (TB) and is tricky to diagnose. It is rarer in young patients, especially in conjunction ...
  44. [44]
    Imaging findings of Pott's disease - PMC - PubMed Central - NIH
    Four different MRI patterns of disease are found in vertebral TB: paradiskal, anterior, central and posterior lesions. The majority of authors suggests that the ...
  45. [45]
    Spinal Tuberculosis - Spine - Orthobullets
    Jul 6, 2021 · Treatment is usually bracing and anti-tuberculosis antibiotics in the absence of neurological defects or mechanical instability.
  46. [46]
    Imaging in tuberculosis - ScienceDirect.com
    High-resolution CT is better than chest radiography in predicting active PTB, with a sensitivity of 96% versus 48%. It has been reported that 18F-FDG PET is ...
  47. [47]
    CNS Tuberculosis Imaging - Medscape Reference
    Oct 3, 2023 · MRI is more sensitive than CT scanning in determining the extent of meningeal and parenchymal involvement. In tuberculous ...
  48. [48]
    Active tuberculosis of spine: Current updates - ScienceDirect.com
    A “cold” abscess, devoid of acute inflammatory symptoms, is a characteristic of spinal TB that can be seen on magnetic resonance imaging (MRI) in more than 70% ...
  49. [49]
    Clinical and Laboratory Diagnosis for Tuberculosis - CDC
    Jan 31, 2025 · Latent TB infection is diagnosed if the person has a positive result from a TB blood test or skin test and a medical evaluation does not ...
  50. [50]
    Integration of cytopathology with molecular tests to improve the lab ...
    Mar 31, 2022 · GeneXpert MTB/RIF and RT-PCR when combined with FNAC detected 61 (63.5%) cases as having Mtb, and the sensitivity and specificity was 100% and ...
  51. [51]
    Atypical Mycobacterial Disease - StatPearls - NCBI Bookshelf - NIH
    Atypical mycobacteria or nontuberculous mycobacteria cause various diseases such as skin and soft tissue infection, lymphadenitis, pulmonary infection, ...Missing: cold | Show results with:cold
  52. [52]
    Multiple Cold Abscesses of a Chest Wall with Ribs Destruction in a ...
    Feb 1, 2024 · Cold abscess of the chest wall is an uncommon disease that is mainly caused by tuberculous infection. Staphylococcal cold abscesses of the ...Missing: definition | Show results with:definition<|separator|>
  53. [53]
    Minimally invasive surgery for paravertebral or psoas abscess with ...
    Jun 6, 2020 · Minimally invasive surgery (MIS) is a common treatment option for paravertebral or psoas abscesses (PAs) in patients with spinal tuberculosis (ST).Mis Technique · Efficacy Evaluation · Discussion
  54. [54]
    Surgical Treatment of a Tuberculous Abscess of the Chest Wall
    Jun 7, 2012 · Complete excision of the abscess and primary closure of the wound with obliteration of space would decrease postoperative complications.Missing: indications | Show results with:indications
  55. [55]
    Surgical Treatment of Tuberculous Cold Abscess of the Chest Wall
    Postoperative Tbc medication for a minimum of 12 months is essential to decrease the risk of a relapse.
  56. [56]
    Cold abscess in the immunocompetent subject | La Tunisie Médicale
    Aim: To describe clinical, diagnostic, therapeutic and prognostic aspects of cold tuberculous abscesses. AbderrahmenMami hospital between 2009 and 2017.
  57. [57]
    Cold abscess in the immunocompetent subject - PubMed
    Tuberculous cold abscess should be evoked in front of any chronique collection occurring especially in a context of risk factors of TB.
  58. [58]
    Functional Prognosis of Spinal Cord Injury Due to Spinal Tuberculosis
    Duration of illness of more than 6 months, spinal cord compression, and spinal extension of abscess are prognostic factors of poor outcomes. In addition ...
  59. [59]
    Mortality and associated factors among patients with TB-HIV co ...
    Aug 2, 2024 · For example, mortality during TB treatment in co-infected patients ranges from 16 to 35%, compared to 4–9% in HIV-negative TB patients [8,9,10].
  60. [60]
    Tuberculosis: Multidrug-resistant (MDR-TB) or rifampicin-resistant ...
    May 20, 2024 · Globally, in 2020, the treatment success rate was 63%, up from 60% in 2019 and 50% in 2012. The two reasons why MDR/RR-TB continues to emerge ...Missing: cold abscess
  61. [61]
    Recurrent complex spinal tuberculosis accompanied by sinus tract ...
    May 2, 2018 · Recurrent complex spinal tuberculosis accompanied by sinus tract formation is one of the most common and complex types of recurrent tuberculosis ...
  62. [62]
    A fast-growing cold skin abscess revealing disseminated ... - PubMed
    Dec 19, 2017 · A fast-growing cold skin abscess revealing disseminated Mycobacterium intracellulare infection in an HIV-infected patient.
  63. [63]
    A high proportion of caseous necrosis, abscess, and ... - PubMed
    Aug 14, 2023 · The proportions of caseous necrosis, acute inflammation, abscess, exudation, and granulation tissue formation in the spinal tuberculosis group were all ...
  64. [64]
    Tuberculosis of spine: neurological deficit - PMC - NIH
    The most dreaded neurological complications in TB spine occur in active stage of disease by mechanical compression, instability and inflammation changes.
  65. [65]
    Diagnosis and management of miliary tuberculosis - PubMed
    Jan 8, 2013 · Miliary TB is a potentially fatal form of TB that results from massive lymphohematogenous dissemination of Mycobacterium tuberculosis bacilli.
  66. [66]
    [Renal amyloidoses in nephrology] - PubMed
    Oct 11, 2019 · Infectious and inflammatory diseases were the main causes found (60%). Tuberculosis alone accounted for 20%. After a mean follow-up period of ...
  67. [67]
    Pulmonary vs. extra-pulmonary tuberculosis hospitalizations in the ...
    Aug 14, 2019 · Inpatient mortality for all three groups was approximately 5.7%. Miliary TB and TB of meninges and central nervous system were positively ...